Carlsmed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Carlsmed, Inc. (CARL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-05
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-06-30 was $600.00K, a 500.00% increase year-over-year.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $600.00K, a 500.00% increase year-over-year.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was $900.00K.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was $200.00K, a 100.00% increase year-over-year.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $1.30M, a 550.00% increase from fiscal 2024.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $200.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-05 | $1.20M 10-Q · filed 2026-08-05 | $2.10M derived: sum of 3 quarters · filed 2026-08-05 | $2.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $600.00K 10-Q · filed 2026-05-05 | $1.50M derived: sum of 2 quarters · filed 2026-05-05 | $1.70M derived: sum of 3 quarters · filed 2026-05-05 | $1.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.10M derived: sum of 2 quarters · filed 2026-02-25 | $1.20M derived: sum of 3 quarters · filed 2026-08-05 | $1.30M 10-K · filed 2026-02-25 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 | $300.00K derived: sum of 2 quarters · filed 2026-08-05 | $400.00K 10-Q · filed 2025-11-06 | $400.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-05 | $100.00K 10-Q · filed 2026-08-05 | $200.00K derived: sum of 3 quarters · filed 2026-08-05 | $300.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-05 | $100.00K derived: sum of 2 quarters · filed 2026-05-05 | $200.00K derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $100.00K derived: sum of 2 quarters · filed 2026-02-25 | $200.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-06 | $200.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |